“…It showed a decrease in UPRDS (unified Parkinson's disease rating scale), which is a clinical measure of Parkinson's disease in patients. In 2017, Kim et al [21] used both Shimjungkyuk and Chengjiang(CV24), Lianquan(CV23) for Parkinson's disease patients because they had diagnosed patients as qi and blood deficiency, heart qi deficiency.…”